CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 50,000 shares at $0.71 ($35,500)
- 4 Open-market buy Chairman & CEO bought 37,500 shares at $0.64 ($24,124)
- 4 Grant or award Chairman & CEO acquired 100,100 shares (grant or award)
- 4 Shares withheld for taxes SVP, Chief Business Officer gave up 1,989 shares (to pay taxes)
- 4 Grant or award SVP, Chief Financial Officer acquired 42,900 shares (grant or award)
- 4 Grant or award SVP, Chief Medical Officer acquired 42,900 shares (grant or award)
- 4 Grant or award SVP, Chief Scientific Officer acquired 24,700 shares (grant or award)
- 4 Shares withheld for taxes Chairman & CEO gave up 21,644 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Business Officer gave up 1,326 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 14,817 shares (to pay taxes)
- 4 Open-market sale SVP, Chief Medical Officer sold 36,000 shares at $1.73 ($62,280)
- 4 Open-market sale SVP, Chief Business Officer sold 27,500 shares at $3.96 ($108,900)
- 4 Open-market sale SVP, Chief Business Officer sold 27,500 shares at $5.00 ($137,500)
- 4 Open-market sale SVP, Chief Scientific Officer sold 50,000 shares at $4.89 ($244,500)
- 4 Open-market sale SVP, Chief Business Officer sold 27,500 shares at $4.89 ($134,475)
- 4 Open-market sale SVP, Chief Business Officer sold 32,960 shares at an average $4.97 ($163,866)
Page 5 of 9 · 180 filings